| Lastest Insider Transactions Of Dyne Therapeutics, Inc. ( DYN ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2024-03-08 | Sell | 29,491 | 26.59 | 784,248 | 2024-03-13 06:04:11 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-03-08 | Sell | 109,601 | 26.11 | 2,861,373 | 2024-03-13 06:04:07 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-03-08 | Option Exercise | 107,825 | 5.54 | 597,351 | 2024-03-13 06:04:07 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2024-03-11 | Sell | 2,615 | 25.65 | 67,082 | 2024-03-12 21:58:16 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-08 | Sell | 88,924 | 26.19 | 2,329,007 | 2024-03-12 21:57:40 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-08 | Option Exercise | 86,252 | 5.54 | 477,836 | 2024-03-12 21:57:40 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-03-08 | Sell | 429,730 | 25.89 | 11,125,776 | 2024-03-12 21:56:20 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-03-08 | Option Exercise | 413,343 | 5.54 | 2,289,920 | 2024-03-12 21:56:20 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2024-03-11 | Sell | 2,081 | 25.70 | 53,482 | 2024-03-12 21:42:33 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-03-07 | Sell | 9,086 | 25.85 | 234,873 | 2024-03-11 21:57:11 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2024-03-07 | Sell | 2,373 | 25.85 | 61,342 | 2024-03-11 21:56:46 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2024-03-07 | Sell | 1,591 | 25.85 | 41,127 | 2024-03-11 21:56:37 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2024-03-07 | Sell | 9,921 | 25.86 | 256,585 | 2024-03-11 21:52:27 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-03-07 | Sell | 2,434 | 25.85 | 62,919 | 2024-03-11 21:50:24 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-03-07 | Sell | 2,273 | 25.85 | 58,757 | 2024-03-11 21:45:41 |
| DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Directior | 2024-03-01 | Sell | 46,534 | 30.05 | 1,398,347 | 2024-03-05 17:08:16 |
| DYN | Dyne Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% Owner | 2024-03-01 | Sell | 46,534 | 30.05 | 1,398,347 | 2024-03-05 17:07:00 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-02-29 | Sell | 100,000 | 28.96 | 2,895,519 | 2024-03-01 21:38:23 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-02-29 | Option Exercise | 100,000 | 5.54 | 554,000 | 2024-03-01 21:38:23 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-02-29 | Sell | 28,528 | 28.46 | 811,865 | 2024-03-01 21:37:54 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-02-29 | Option Exercise | 28,528 | 0.73 | 20,825 | 2024-03-01 21:37:54 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-02-29 | Sell | 12,740 | 28.05 | 357,296 | 2024-03-01 21:37:15 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-02-29 | Option Exercise | 12,740 | 1.03 | 13,122 | 2024-03-01 21:37:15 |
| DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Directior | 2024-02-26 | Sell | 807,838 | 24.30 | 19,626,902 | 2024-02-28 19:15:53 |
| DYN | Dyne Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-26 | Sell | 807,838 | 24.30 | 19,626,902 | 2024-02-28 19:13:18 |
| DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Directior | 2024-02-21 | Sell | 500,789 | 22.64 | 11,339,780 | 2024-02-23 18:59:58 |
| DYN | Dyne Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-21 | Sell | 500,789 | 22.64 | 11,339,780 | 2024-02-23 18:58:32 |
| DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Directior | 2024-02-15 | Sell | 510,152 | 23.26 | 11,867,292 | 2024-02-20 18:36:47 |
| DYN | Dyne Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% Owner | 2024-02-15 | Sell | 510,152 | 23.26 | 11,867,292 | 2024-02-20 18:35:34 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2024-02-12 | Sell | 5,493 | 25.07 | 137,710 | 2024-02-14 16:27:23 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2024-01-26 | Sell | 100 | 25.00 | 2,500 | 2024-01-26 19:49:51 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-01-26 | Sell | 20,000 | 24.53 | 490,510 | 2024-01-26 19:48:29 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-01-26 | Option Exercise | 20,000 | 0.73 | 14,600 | 2024-01-26 19:48:29 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-26 | Sell | 13,000 | 24.34 | 316,420 | 2024-01-26 19:47:53 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-26 | Option Exercise | 13,000 | 1.03 | 13,390 | 2024-01-26 19:47:53 |
| DYN | Dyne Therapeutics, Inc. | Kersten Dirk | Directior 10% Owner | 2024-01-09 | Buy | 1,714,285 | 17.50 | 29,999,988 | 2024-01-11 16:31:55 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-01-03 | Sell | 269,719 | 18.66 | 5,032,915 | 2024-01-04 21:49:44 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | 2024-01-03 | Option Exercise | 269,719 | 4.37 | 1,179,811 | 2024-01-04 21:49:44 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-03 | Sell | 87,779 | 18.57 | 1,629,985 | 2024-01-04 21:48:23 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2024-01-03 | Option Exercise | 68,000 | 1.03 | 70,040 | 2024-01-04 21:48:23 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-01-02 | Sell | 31,900 | 16.59 | 529,194 | 2024-01-04 21:47:38 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2024-01-02 | Option Exercise | 20,000 | 0.73 | 14,600 | 2024-01-04 21:47:38 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-03 | Sell | 13,000 | 18.81 | 244,530 | 2024-01-04 21:46:58 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | 2024-01-03 | Option Exercise | 13,000 | 1.03 | 13,390 | 2024-01-04 21:46:58 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-12-14 | Sell | 2,376 | 12.02 | 28,560 | 2023-12-14 16:59:25 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-12-11 | Sell | 1,380 | 10.72 | 14,794 | 2023-12-12 17:35:13 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2023-12-11 | Sell | 1,245 | 10.72 | 13,346 | 2023-12-12 17:34:48 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-12-11 | Sell | 1,616 | 10.72 | 17,324 | 2023-12-12 17:34:21 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2023-12-11 | Sell | 2,666 | 10.66 | 28,413 | 2023-12-12 17:33:28 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-12-11 | Sell | 7,585 | 10.72 | 81,311 | 2023-12-12 17:33:03 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2023-12-11 | Sell | 1,467 | 10.72 | 15,726 | 2023-12-12 17:32:28 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-12-04 | Sell | 2,553 | 12.01 | 30,662 | 2023-12-06 18:13:25 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-11-02 | Sell | 9,939 | 7.40 | 73,549 | 2023-11-02 17:16:26 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-09-18 | Sell | 1,290 | 9.41 | 12,139 | 2023-09-20 16:49:38 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2023-09-18 | Sell | 1,261 | 9.41 | 11,866 | 2023-09-20 16:49:15 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-09-18 | Sell | 2,672 | 9.41 | 25,144 | 2023-09-20 16:48:44 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-09-18 | Sell | 12,032 | 9.41 | 113,221 | 2023-09-20 16:47:47 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-18 | Sell | 1,436 | 9.41 | 13,513 | 2023-09-20 16:47:17 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2023-09-12 | Sell | 1,707 | 10.41 | 17,770 | 2023-09-13 19:56:07 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-09-12 | Sell | 1,397 | 10.41 | 14,543 | 2023-09-13 19:53:43 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | 2023-09-12 | Sell | 1,266 | 10.41 | 13,179 | 2023-09-13 19:53:04 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-09-12 | Sell | 1,635 | 10.41 | 17,020 | 2023-09-13 19:51:52 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-09-12 | Sell | 7,672 | 10.41 | 79,866 | 2023-09-13 19:50:47 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2023-09-12 | Sell | 1,484 | 10.41 | 15,448 | 2023-09-13 19:50:06 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-06-13 | Sell | 51,390 | 12.71 | 653,178 | 2023-06-15 17:46:17 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-06-13 | Option Exercise | 40,000 | 1.03 | 41,200 | 2023-06-15 17:46:17 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2023-06-12 | Sell | 2,259 | 12.68 | 28,649 | 2023-06-14 18:40:50 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-06-13 | Sell | 1,625 | 12.43 | 20,199 | 2023-06-14 18:40:19 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2023-06-13 | Sell | 1,698 | 12.43 | 21,106 | 2023-06-14 18:40:00 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2023-06-13 | Sell | 1,475 | 12.43 | 18,334 | 2023-06-14 18:39:34 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-06-08 | Sell | 325,330 | 12.90 | 4,195,797 | 2023-06-12 21:22:04 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-06-08 | Option Exercise | 278,030 | 1.03 | 286,371 | 2023-06-12 21:22:04 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2023-03-14 | Sell | 1,311 | 13.33 | 17,476 | 2023-03-15 17:51:13 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2023-03-13 | Sell | 2,209 | 13.18 | 29,116 | 2023-03-15 17:50:33 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2023-03-14 | Sell | 1,559 | 13.33 | 20,781 | 2023-03-15 17:50:09 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2023-03-14 | Sell | 7,441 | 13.33 | 99,189 | 2023-03-15 17:49:37 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2023-03-14 | Sell | 7,318 | 13.33 | 97,549 | 2023-03-15 17:49:01 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2023-03-14 | Sell | 1,416 | 13.33 | 18,875 | 2023-03-15 17:48:38 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2023-01-18 | Sell | 10,000 | 14.03 | 140,300 | 2023-01-23 08:27:05 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2023-01-18 | Option Exercise | 10,000 | 0.73 | 7,300 | 2023-01-23 08:27:05 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2023-01-09 | Sell | 30,150 | 11.57 | 348,836 | 2023-01-11 16:56:59 |
| DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Directior | 2022-12-12 | Buy | 934,581 | 10.70 | 10,000,017 | 2022-12-14 16:56:38 |
| DYN | Dyne Therapeutics, Inc. | Atlas Venture Opportunity Fund II, L.P. | 10% Owner | 2022-12-12 | Buy | 934,581 | 10.70 | 10,000,017 | 2022-12-14 16:55:15 |
| DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | 2022-12-09 | Sell | 312 | 10.87 | 3,391 | 2022-12-13 17:06:31 |
| DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | 2022-12-09 | Sell | 472 | 10.87 | 5,131 | 2022-12-13 17:05:28 |
| DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | 2022-12-09 | Sell | 751 | 10.87 | 8,163 | 2022-12-13 17:05:21 |
| DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | 2022-12-09 | Sell | 628 | 10.87 | 6,826 | 2022-12-13 17:04:51 |
| DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | 2022-12-09 | Sell | 3,322 | 10.87 | 36,110 | 2022-12-13 17:04:20 |
| DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | 2022-12-09 | Sell | 680 | 10.87 | 7,392 | 2022-12-13 17:03:32 |
